Perrigo Stock Hits New 52-Week High (PRGO)

NEW YORK ( TheStreet) -- Perrigo Company (Nasdaq: PRGO) hit a new 52-week high Thursday as it is currently trading at $104.84, above its previous 52-week high of $104.70 with 393,802 shares traded as of 10:05 a.m. ET. Average volume has been 1.2 million shares over the past 30 days.

Perrigo has a market cap of $9.09 billion and is part of the health care sector and drugs industry. Shares are up 5.9% year to date as of the close of trading on Wednesday.

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide. The company has a P/E ratio of 27.1, below the average drugs industry P/E ratio of 27.3 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Perrigo as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, notable return on equity, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Perrigo Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.